SightMD Acquires Hatsis Laser Vision to Expand Premier Laser Vision Correction Services

On July 23, 2019, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that ophthalmic hospital SightMD announced the acquisition of ophthalmology clinic Hatsis Laser Vision (Hatsis) to expand its market presence in Long Island, New York. No financial terms of the acquisition were disclosed.

Hatsis, located in New York, USA, is a leading ophthalmology specialty clinic. The institution offers services such as cataract surgery, Laser-Assisted In Situ Keratomileusis (LASIK), and retinal examinations. Hatsis boasts a professional team of ophthalmologists, including retinal specialist Philip Bonanno and Leah Shanfeld, M.D.

Hatsis specializes in laser refractive surgery for myopia correction, offering six procedures: Photorefractive Keratectomy (PRK), Laser-Assisted In Situ Keratomileusis (LASIK), Laser-Assisted Subepithelial Keratectomy (LASEK), wavefront-guided excimer laser surgery (Torsion LASIK), femtosecond laser surgery, and small-incision lenticule extraction (SMILE).

Dr. Alexander Hatsis, the founder of Hatsis Laser Vision, was the first surgeon to perform LASIK surgery. Dr. Hatsis is also one of the FDA-recognized experts on laser vision correction products in the United States and participated in the FDA approval process for phakic intraocular lenses (Phakic Implant Lenses). Passionate about his work, Dr. Hatsis frequently joins global medical volunteer teams to provide support in underserved regions with limited healthcare resources. He has been named a “Top Doctor” by Castle Connolly for six consecutive years and is regarded by the ophthalmology industry as the “Humanitarian of the Year.”

SightMD is an ophthalmic hospital headquartered in New York, USA, with branches in 32 locations across the United States, including Long Island, Westchester, and Manhattan. The hospital is dedicated to meeting patients' medical needs through advanced technology. SightMD offers a range of diagnostic and treatment services, including cataract surgery, intraocular lens implantation, glaucoma prevention and management, retinal disease treatment, LASIK laser vision correction, neuro-ophthalmic surgery, and hearing correction.

It is reported that SightMD has received funding from Chicago Pacific Founders. Chicago Pacific Founders is a leading private equity firm primarily investing in the healthcare services and life sciences sectors.

SightMD encompasses North Shore Eye Care, a globally leading laser vision surgery institution, and Long Island Eye Surgical Care, a specialized eye hospital. Furthermore, the healthcare organization is dedicated to addressing patients' ocular health issues and boasts world-class ophthalmologist training programs. To date, SightMD employs more than 50 specialized ophthalmologists and has a track record of over 50 years in delivering excellent clinical care.

Dr. Jeffrey Martin, Co-Founder and President of SightMD, stated, “With the addition of Dr. Hatsis, SightMD’s patient-centered ophthalmology clinical team will be further strengthened. I have admired Dr. Hatsis for many years and am honored to have the opportunity to partner with him.”

Dr. Hatsis stated, “SightMD’s values align closely with our own, and Hatsis Clinic will collaborate with them to provide high-quality care and treatment solutions for ophthalmology patients.”

(Compiled by Xu Xiaoxue)